About Bend Research
Bend Research is a Healthcare company based in Bend (United States) founded in 1975, and was acquired by Capsugel in September 2013. It operates as a CDMO specializing in solutions for bioavailability enhancement, modified release and inhalation dosage form development. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Akums, Unither, Recipharm, Jubilant Life Sciences and Nectar Lifesciences and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Bend Research, acquired by Capsugel in October 2013, which in turn was acquired by Lonza in December 2016, was engaged in the design, development, and manufacturing of dosage forms while specializing in spray-dried dispersions, hot-melt extrusion, controlled-release and inhalation formulations. Their services included formulation and dosage-form development, process development and optimization, cGMP manufacturing for clinical trials, among others. The company had technologies for solubility enhancement, modified release, and inhalation dosage form development. They had developed a proprietary Modular Automatic Sampling Technology (MAST) platform in order to address sampling challenges such as sterility maintenance, real-time monitoring and processing of high-density cell solutions.
- Headquarters Bend, United States
- Stage Acquired
- SectorsHealthcare
- Website bendresearch.com
- Social LinkedIn Facebook
- Acquired by Capsugel (Sep 2013)
Investors in Bend Research
Bend Research has secured backing from 1 investor. Prominent investors backing the company include Capsugel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dosage forms are delivered for preclinical, clinical, and commercial supply. | 1875 | capsugel.com | Morristown, United States |
Investor details for Bend Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Bend Research
2 dated milestones of Bend Research across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Bend Research is founded.
- Exit Acquired by Capsugel.
Competitors of Bend Research
Bend Research has 10 listed competitors in our database, 4 of them funded. They include Akums, Unither, Recipharm, Jubilant Life Sciences and Nectar Lifesciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| aenova-group.com | 2008 | Starnberg, Germany | – | – | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| zambon.com | 1906 | Bresso, Italy | – | – | APIs and finished drugs are developed and manufactured in pharmaceuticals. | |
| dispersoltech.com | 2007 | Georgetown, United States | – | 54 | Solid dispersion technology for pharmaceutical solubility enhancement is developed. |
Detailed competitors of Bend Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bend Research
Websites that share an audience with Bend Research (bendresearch.com).
Websites whose visitors overlap most with Bend Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cellectar.com | 100% | 11.2K | #2,631,153 | View details | |
| biomodels.com | 97% | 2.5K | #9,156,523 | View details | |
| aprecia.com | 96% | 2.6K | #5,861,353 | View details | |
| certara.com | 60% | 98.2K | #495,649 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Bend Research (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bend Research
Bend Research was founded in 1975.
Bend Research is headquartered in Bend, United States. It is registered at Bend, Oregon, United States.
Bend Research, acquired by Capsugel in October 2013, which in turn was acquired by Lonza in December 2016, was engaged in the design, development, and manufacturing of dosage forms while specializing in spray-dried dispersions, hot-melt extrusion, controlled-release and inhalation formulations. Their services included formulation and dosage-form development, process development and optimization, cGMP manufacturing for clinical trials, among others. The company had technologies for solubility enhancement, modified release, and inhalation dosage form development. They had developed a proprietary Modular Automatic Sampling Technology (MAST) platform in order to address sampling challenges such as sterility maintenance, real-time monitoring and processing of high-density cell solutions.
Bend Research's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Bend Research has 1 investor. Key investors include Capsugel.
Yes. Bend Research was acquired by Capsugel in September 2013.